Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Aurora, Colorado 80040


Purpose:

The purpose of this study is to test whether SU011248 has activity and is safe compared to interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (RCC).


Criteria:

Inclusion Criteria: - Histologically confirmed renal cell carcinoma of clear cell histology with metastases - Evidence of measurable disease by radiographic technique - Eastern Cooperative Oncology Group [ECOG] performance status of 0 or 1 Exclusion Criteria: - Prior systemic (including adjuvant or neoadjuvant) therapy of any kind for RCC - History of or known brain metastases - Serious acute or chronic illness or recent history of significant cardiac abnormality


NCT ID:

NCT00083889


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

Aurora, Colorado 80040
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.